TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cann Group ( (AU:CAN) ) has issued an announcement.
Cann Group Limited has announced the issuance of over 15 million ordinary fully paid shares to a prominent Australian private credit fund. This move is intended to satisfy the payment of capitalized interest, as approved by shareholders during an Extraordinary General Meeting in May 2025. This strategic financial maneuver is expected to impact the company’s financial structure and enhance its market positioning by addressing its capital requirements.
The most recent analyst rating on (AU:CAN) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Cann Group stock, see the AU:CAN Stock Forecast page.
More about Cann Group
Cann Group Limited operates in the pharmaceutical industry, focusing on the cultivation and production of medicinal cannabis products. The company is primarily engaged in the development and commercialization of cannabis-based therapies and products, targeting both domestic and international markets.
YTD Price Performance: -71.79%
Average Trading Volume: 4,181,369
Technical Sentiment Signal: Sell
Current Market Cap: A$8.66M
For a thorough assessment of CAN stock, go to TipRanks’ Stock Analysis page.